Latest therapeutics News | Page 11

Proposed rescheduling of medications – oral meloxicam and injectable lidocaine – submissions due
Moderna to build mRNA vaccine manufacturing facility in Australia
Bacteria biochemistry controlled with insoluble material
Common osteoporosis medication boosts immune response in lun
Seventh meeting of Multilateral Leaders Task Force on Covid Vaccines, Therapeutics and Diagnostics
AHPPC statement on Omicron public health implications and response options
Medical Research Future Fund support for clincial trials of mRNA-based vaccines and therapeutics
Researchers working on injection-free cell therapy for diabetes
QIMR Berghofer attracts support for potential multiple sclerosis treatment
Significant investments in data and digital capability to drive transformation of health and disability system
TaBriX, University and TB Alliance to develop drug-resistant tuberculosis treatments
Victoria to become home of mRNA vaccine manufacturing
Top 3 Covid vaccine questions – Boosters, assessing Omicron severity, and anxiety around holiday period
New strategy for treating cancer recognised with Victoria Prize
Victoria To Become Home Of mRNA Vaccine Manufacturing
Tumors differ depending on age of cancer patients
Targeting brain’s immune cells may block Alzheimer’s
WHO recommends against use of convalescent plasma to treat Covid
NZ secures new Pfizer Covid medicine
Australian Cancer Research Foundation awards $2.6M to establish International Centre for Cancer Glycomics
THC in blood and saliva are poor measures of cannabis impairment
QIMR Berghofer signs licensing, research and manufacturing deal for new cellular immunotherapy with US company Cellevolve Bio
Major gift helps launch Canine Health Center
CSL Joins StartX Community
Investment market update – Omicron
Victoria produces Australia’s first mRNA Covid vaccine candidate
Victoria Makes Australia’s First mRNA Vaccine Candidate
Radiometals and Radiohalogens: Potential New Combination for Cancer Treatment
Classification of Omicron: SARS-CoV-2 Variant of Concern
Centenary Institute receives $1.8m in funding for cardiovascular research
WHO and MPP announce first transparent, global, non-exclusive licence for Covid technology
Backing Victorian Women In mRNA And Medical Research
Making more effective and efficient RNA therapeutics
Antibiotic resistance in dentistry – ADA addresses problem
AZD8601 EPICCURE Phase II trial demonstrated safety and tolerability in patients with heart failure
Monash University launches new Centre to transform treatments for Australians living with mental health disorders
Tissue physics plays key role in tumor growth
Winner of 2021’s Prime Minister’s Prize for Innovation congratulated
$4.5m in NHMRC Ideas Grants supports quest to improve human health
AstraZeneca advances ambition to redefine care for blood cancer at ASH 2021
Flicking inflammation off-switch
Pharmaceutical start up named WA Innovator of Year 2021
McGowan Government launches first Health and Medical Life Sciences Industry Strategy
WHO-Unitaid statement on MPP licensing agreement for molnupiravir
Covid treatments – what are they and how do they work?
Researchers create mirror-image peptides that can neutralize SARS-CoV-2
Researchers’ lab-grown muscles used to study Duchenne muscular dystrophy, develop treatments
UQ startup gets $1.3 million international backing for liver disease treatment